Tenpoint Therapeutics, Ltd. is rolling out a new telehealth prescribing program for YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1.
The launch comes just 7 months after the presbyopia eye drop debuted to the U.S. commercial market.
Let’s get a refresher on YUVEZZI.
Important to note: The FDA granted its approval at the beginning of 2026.
Its claim to fame: As the first and only combination drop of carbachol and brimonidine tartrate, YUVEZZI is reported to achieve miosis within 30 minutes of a once-daily dosing—with relief lasting up to 10 hours.
Check out our rundown for what to know about this pupil-modulating, fixed-dose eye drop formulated to offer rapid symptom relief and long-term disease management.
And this program?
The YUVEZZI telehealth program is designed to virtually connect adults experiencing blurry close-up vision with an eyecare provider (ECP) to undergo an online evaluation and determine potential eligibility for a prescription fill of YUVEZZI.
To clarify: This online evaluation can be conducted by either an ophthalmologist or optometrist.
What does the evaluation entail, exactly?
The evaluation is essentially an online medical questionnaire on a potential patient’s medical history, medical conditions, and current medications
To note: Regarding the consultation component, the exact type of interaction (audio, video, or digital consultation) will be dependent on which state the patient resides in.
- See here for audio and video consultation requirements.
- See here for digital consultation requirements.
So this telehealth option is available in all 50 states?
While OrderYUVEZZI.com is available in all U.S. states (plus the District of Columbia), this new telehealth option is currently only offered in 46 states. The following are excluded:
- Arkansas
- Kansas
- North Carolina
- South Dakota
Noted. So explain how it all works.
The program is part of a five-step OrderYUVEZZI plan for patients to have their prescription filled that involves:
- Registering by setting up a YUVEZZI account
- Completing a medical questionnaire, with responses to be reviewed by a licensed telehealth provider to determine prescription eligibility
- Paying for the ECP review (at present, health insurance is not accepted; however, FSA and HSA cards are accepted)
- Receiving the ECP’s review decision
- (If eligibility is confirmed), receiving the prescription delivered directly to their door
So does this telehealth exam replace standard ECP eye exams?
Not at all. In fact, Tenpoint has intentionally described the program as being designed to complement—not replace, take note—ECP care for adults.
The company further highlighted this distinction by emphasizing the critical role an in-person eye exam still holds in a patient’s overall vision care.
- “Participants will be encouraged to establish and maintain care with a local ECP for their ongoing vision and eye health needs,” the company stated. “While telehealth can be a flexible, fast avenue for appropriate patients to use YUVEZZI, regular care from a local ECP remains necessary for overall eye health.”
For context: State and national organizations have previously voiced concerns over the use of telemedicine in eyecare, with patient health and safety at the forefront of their arguments.
- And recent clinical research has also confirmed that, though helpful to some degree, virtual exams fall short in comparison to in-person eye examinations.
Noted. So how can interested patients get started with this program?
We’d recommend clicking here to create an Order YUVEZZI online account.